Myriad Genetics Inc (NASDAQ:MYGN)

During the Trading Day
34.27 -1.07 / -3.03%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
34.27 0.00 / 0.00%
 
Volume: 10.5K

Today’s Trading

Previous close35.34
Today’s open35.49
Day’s range33.98 - 35.49
Volume940,705
Average volume (3 months)850,579
Market cap$2.5B
Dividend yield--
Data as of 3:59pm ET, 04/20/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-37.28%
Earnings growth (next 5 years)+14.19%
Revenue growth (last year)+26.92%
P/E ratio23.7
Price/Sales3.31
Price/Book3.61

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+0.48+0.77%
PTCTPTC Therapeutics Inc-1.28-1.81%
CBPOChina Biologic Produ...+3.60+3.75%
LCILannett Company Inc+1.86+2.87%
Data as of 4:00pm ET, 04/20/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers